Moderna (Germany) Price Prediction
| 0QF Stock | EUR 38.58 1.63 4.41% |
Oversold Vs Overbought
48
Oversold | Overbought |
Using Moderna hype-based prediction, you can estimate the value of Moderna from the perspective of Moderna response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Moderna to buy its stock at a price that has no basis in reality. In that case, they are not buying Moderna because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Moderna after-hype prediction price | EUR 38.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Moderna |
Moderna After-Hype Price Prediction Density Analysis
As far as predicting the price of Moderna at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Moderna or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Moderna, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Moderna Estimiated After-Hype Price Volatility
In the context of predicting Moderna's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Moderna's historical news coverage. Moderna's after-hype downside and upside margins for the prediction period are 35.40 and 41.76, respectively. We have considered Moderna's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Moderna is very steady at this time. Analysis and calculation of next after-hype price of Moderna is based on 3 months time horizon.
Moderna Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Moderna is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Moderna backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Moderna, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.67 | 3.18 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
38.58 | 38.58 | 0.00 |
|
Moderna Hype Timeline
Moderna is presently traded for 38.58on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Moderna is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at -0.67%. %. The volatility of related hype on Moderna is about 0.0%, with the expected price after the next announcement by competition of 38.58. About 68.0% of the company shares are owned by institutions such as pension funds. The book value of Moderna was presently reported as 49.67. The company has Price/Earnings (P/E) ratio of 237.44. Moderna recorded earning per share (EPS) of 22.69. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out Moderna Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Moderna Stock please use our How to Invest in Moderna guide.Moderna Related Hype Analysis
Having access to credible news sources related to Moderna's direct competition is more important than ever and may enhance your ability to predict Moderna's future price movements. Getting to know how Moderna's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Moderna may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NOVA | Novo Nordisk AS | 0.00 | 0 per month | 0.00 | (0.18) | 2.94 | (2.70) | 6.32 | |
| CSJA | CSL LTD SPONADR | 0.00 | 0 per month | 0.00 | (0.11) | 2.38 | (2.34) | 6.98 | |
| CSJ | CSL Limited | 0.00 | 0 per month | 0.00 | (0.12) | 2.11 | (2.10) | 4.47 | |
| MBG | Mercedes Benz Group AG | 0.00 | 0 per month | 0.00 | (0.06) | 1.98 | (2.16) | 9.12 | |
| VX1 | Vertex Pharmaceuticals Incorporated | 0.00 | 0 per month | 0.00 | (0.08) | 3.36 | (2.69) | 20.51 | |
| 0QF | Moderna | 0.00 | 0 per month | 0.00 | (0.23) | 3.70 | (6.47) | 15.59 | |
| 1FW1 | WUXI BIOLOGICS UNSPADR2 | 0.00 | 0 per month | 3.96 | 0.15 | 11.85 | (6.76) | 28.36 | |
| 22UA | BioNTech SE | 0.00 | 0 per month | 2.76 | 0.05 | 5.82 | (4.43) | 14.85 |
Moderna Additional Predictive Modules
Most predictive techniques to examine Moderna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Moderna using various technical indicators. When you analyze Moderna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Moderna Predictive Indicators
The successful prediction of Moderna stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Moderna, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Moderna based on analysis of Moderna hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Moderna's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Moderna's related companies.
Story Coverage note for Moderna
The number of cover stories for Moderna depends on current market conditions and Moderna's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Moderna is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Moderna's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Moderna Short Properties
Moderna's future price predictability will typically decrease when Moderna's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Moderna often depends not only on the future outlook of the potential Moderna's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Moderna's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 385 M |
Complementary Tools for Moderna Stock analysis
When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |